These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27076303)

  • 1. Developing Anti-tick Vaccines.
    Rodríguez-Mallon A
    Methods Mol Biol; 2016; 1404():243-259. PubMed ID: 27076303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of ticks resistant to immunization with Bm86 in cattle vaccinated with the recombinant antigen Bm95 isolated from the cattle tick, Boophilus microplus.
    García-García JC; Montero C; Redondo M; Vargas M; Canales M; Boue O; Rodríguez M; Joglar M; Machado H; González IL; Valdés M; Méndez L; de la Fuente J
    Vaccine; 2000 Apr; 18(21):2275-87. PubMed ID: 10717348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against ticks (Boophilus spp.): the experience with the Bm86-based vaccine Gavac.
    de la Fuente J; Rodríguez M; Montero C; Redondo M; García-García JC; Méndez L; Serrano E; Valdés M; Enríquez A; Canales M; Ramos E; Boué O; Machado H; Lleonart R
    Genet Anal; 1999 Nov; 15(3-5):143-8. PubMed ID: 10596754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological control of ticks through vaccination with Boophilus microplus gut antigens.
    De La Fuente J; Rodríguez M; García-García JC
    Ann N Y Acad Sci; 2000; 916():617-21. PubMed ID: 11193686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the identification and characterization of protective antigens for recombinant vaccines against tick infestations.
    de la Fuente J; Kocan KM
    Expert Rev Vaccines; 2003 Aug; 2(4):583-93. PubMed ID: 14711342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quest for a universal vaccine against ticks: cross-immunity insights.
    Parizi LF; Githaka NW; Logullo C; Konnai S; Masuda A; Ohashi K; da Silva Vaz I
    Vet J; 2012 Nov; 194(2):158-65. PubMed ID: 22766309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticks and antibodies: May parasite density and tick evasion influence the outcomes following immunization protocols?
    Ferreira Leal B; Sanchez Ferreira CA
    Vet Parasitol; 2021 Dec; 300():109610. PubMed ID: 34735848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field studies and cost-effectiveness analysis of vaccination with Gavac against the cattle tick Boophilus microplus.
    de la Fuente J; Rodríguez M; Redondo M; Montero C; García-García JC; Méndez L; Serrano E; Valdés M; Enriquez A; Canales M; Ramos E; Boué O; Machado H; Lleonart R; de Armas CA; Rey S; Rodríguez JL; Artiles M; García L
    Vaccine; 1998 Feb; 16(4):366-73. PubMed ID: 9607057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocktail Anti-Tick Vaccines: The Unforeseen Constraints and Approaches toward Enhanced Efficacies.
    Ndawula C; Tabor AE
    Vaccines (Basel); 2020 Aug; 8(3):. PubMed ID: 32824962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tick vaccines: current status and future directions.
    de la Fuente J; Contreras M
    Expert Rev Vaccines; 2015; 14(10):1367-76. PubMed ID: 26289976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated control of acaricide-resistant Boophilus microplus populations on grazing cattle in Mexico using vaccination with Gavac and amidine treatments.
    Redondo M; Fragoso H; Ortíz M; Montero C; Lona J; Medellín JA; Fría R; Hernández V; Franco R; Machado H; Rodríguez M; de la Fuente J
    Exp Appl Acarol; 1999 Oct; 23(10):841-9. PubMed ID: 10581714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune response of dairy cattle immunized with rBm95 (KU-VAC1) derived from Thai Rhipicephalus microplus.
    Jittapalapong S; Kaewhom P; Kengradomkij C; Saratapan N; Canales M; de la Fuente J; Stich RW
    Transbound Emerg Dis; 2010 Apr; 57(1-2):91-5. PubMed ID: 20537117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ten-year review of commercial vaccine performance for control of tick infestations on cattle.
    de la Fuente J; Almazán C; Canales M; Pérez de la Lastra JM; Kocan KM; Willadsen P
    Anim Health Res Rev; 2007 Jun; 8(1):23-8. PubMed ID: 17692140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Tick Antigen Discovery and Anti-Tick Vaccine Development.
    Abbas MN; Jmel MA; Mekki I; Dijkgraaf I; Kotsyfakis M
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated control of Boophilus microplus ticks in Cuba based on vaccination with the anti-tick vaccine Gavac.
    Valle MR; Mèndez L; Valdez M; Redondo M; Espinosa CM; Vargas M; Cruz RL; Barrios HP; Seoane G; Ramirez ES; Boue O; Vigil JL; Machado H; Nordelo CB; Piñeiro MJ
    Exp Appl Acarol; 2004; 34(3-4):375-82. PubMed ID: 15651533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposed and concealed antigens as vaccine targets for controlling ticks and tick-borne diseases.
    Nuttall PA; Trimnell AR; Kazimirova M; Labuda M
    Parasite Immunol; 2006 Apr; 28(4):155-63. PubMed ID: 16542317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Rhipicephalus (Boophilus) microplus Bm86 against Hyalomma dromedarii and Amblyomma cajennense tick infestations in camels and cattle.
    Rodríguez-Valle M; Taoufik A; Valdés M; Montero C; Ibrahin H; Hassan SM; Jongejan F; de la Fuente J
    Vaccine; 2012 May; 30(23):3453-8. PubMed ID: 22446633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhipicephalus (Boophilus) microplus embryo proteins as target for tick vaccine.
    Seixas A; Oliveira P; Termignoni C; Logullo C; Masuda A; da Silva Vaz I
    Vet Immunol Immunopathol; 2012 Jul; 148(1-2):149-56. PubMed ID: 21620488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Bm86 antigen in different strains of Boophilus microplus and effectiveness of immunization with recombinant Bm86.
    Penichet M; Rodriguez M; Castellano O; Mandado S; Rojas Y; Rubiera R; Sanchez P; Lleonart R; De La Fuente J
    Parasite Immunol; 1994 Sep; 16(9):493-500. PubMed ID: 7838598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of the ATAQ peptide and its evaluation as an immunogen to develop a Rhipicephalus vaccine.
    Aguirre Ade A; Lobo FP; Cunha RC; Garcia MV; Andreotti R
    Vet Parasitol; 2016 May; 221():30-8. PubMed ID: 27084468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.